
Tetracyclineisalight-sensitivebacteriostaticpolyketideantibioticfrequentlyusedinawiderangeofin-vitrocellcultureapplications.Tetracycline(achromycin)isafirst-generationtetracyclineantibioticandwasfirstidentifiedin1953byChemistLloydConover’steamatPfizer,incollaborationwithR.B.WoodwardofHarvardUniversity.TetracyclineisanaturallyoccurringantibioticfromS.aureofaciens,S.rimosus,andS.viridofacienthatshowswiderangingactivityagainstbothgram-negativeandgram-positivebacteria.
Tetracyclineisaproteinsynthesisinhibitor.Tetracyclinebindthe30sribosomalsubunit,preventingtheaminoacyl-tRNAfromattachingtotheAsite.Consequently,proteinsynthesisisinhibited.ResistancetotetracyclinearisesfromlossofcellwallpermeABIlity,tetracyclineefflux,ribosomeprotectionandtetracyclinemodification.
Tetracyclineisusedtostudytranscriptionalactivation.KnowledgeoftetracyclineledtothedevelopmentofapopularinducIBLeexpressionsystemineukaryoticcellsknownasTet-OffandTet-On.Tetracyclineisalsousedinmultidrugresistancestudiesandincellcultureapplicationsasaselectiveagent.Additionally,itpromotesexpressionoftheP450proteins.
TOKU-Eoffersthreeformsoftetracycline:tetracyclineHCL(T004),tetracycline,USP(T051),andtetracycline,EP(T016).Tetracycline,USPandtetracycline,EParesparinglysolubleinaqueoussolutionat0.231mg/mL.TetracyclineHCl,isslightlysolubleinaqueoussolutionat10mg/mL.Tetracycline,USP(T051)conformstoUnitedStatesPharmcopeiaspecifications.
CASNumber
60-54-8
MolecularFormula
C22H24N2O8·xH2O
MechanismofAction
Tetracyclineinhibitsbacterialgrowthingram-positiveandgram-negativebacteriabydisruptingcodon-anticodoninteractionsattheribosome,thusblockingproteinsynthesis.Specifically,tetracyclinebindstoasinglesiteonthe30Sribosomalsubunitandinhibitproteinsynthesisbyblockingtheattachmentofchargedaminoacyl-tRNAtotheAsiteontheribosome.Thus,theypreventintroductionofnewaminoacidstothenascentpeptidechain. Mammaliancellsarenotvulnerabletotheeffectoftetracyclineasthesecellscontainno30Sribosomalsubunitssodonotaccumulatethedrug.
StorageConditions
2-8°C
TariffCode
2941.30.0000
Spectrum
Tetracyclineisabroadspectrumantibiotic,effectiveagainstbothgram-positive,gram-negativebacteria,andmycoplasma.Afewspeciesofbacteriadisplayintrinsicresistancetotetracycline,includingPseudomonasaeruginosa.Acquired(asopposedtoinherent)resistancehasproliferatedinmanypathogenicorganismsandgreatlyerodedtheversatilityofTetracyclinederivatives.ResistanceamongstStaphylococcus,Streptococcus,Neisseriagonorrhoeae,andmembersoftheEnterobacteriaceaeisnowquitecommon.Tetracyclinesshowactivityagainstprotozoanparasitesaswell.